文章投稿建议# Biology - 生物学
a*1
1 楼
这三年一直做HCV免疫耐受机制的研究，最近写了一篇文章投稿到hepatology,编辑
部直接拒掉了，意见如下：
While the study was well done, it was considered to be of somewhat
diminished impact for the readership of Hepatology in light of curative
therapies for HCV.
查了下，自从去年发现了两种治疗HCV特效药，现在大家基本都认可HCV可治愈了，这
种免疫学机制文章hepatology估计很难发了，请问是不是往非专业期刊投好一些，比如
NC,PNAS,BLOOD,PLOS PATHOGEN等。谢谢！
部直接拒掉了，意见如下：
While the study was well done, it was considered to be of somewhat
diminished impact for the readership of Hepatology in light of curative
therapies for HCV.
查了下，自从去年发现了两种治疗HCV特效药，现在大家基本都认可HCV可治愈了，这
种免疫学机制文章hepatology估计很难发了，请问是不是往非专业期刊投好一些，比如
NC,PNAS,BLOOD,PLOS PATHOGEN等。谢谢！